Literature DB >> 8383247

Effect of a capsid-stabilizing pyridazinamine, R 78206, on the eclipse and intracellular location of poliovirus.

O Ofori-Anyinam1, R Vrijsen, P Kronenberger, A Boeyé.   

Abstract

R 78206 (a pyridazinamine derivative) inhibits the formation of poliovirus eclipse particles. Its effect on the intracellular location of poliovirus was studied by separating subcellular fractions in iso-osmotic Nycodenz gradients. The compound did not inhibit internalization of intact virus into small lipid vesicles, but it did inhibit the release of virus from these vesicles and its entry into lysosomes.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8383247      PMCID： PMC240400     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  15 in total

1.  Compartmentalization of subviral particles during poliovirus eclipse in HeLa cells.

Authors:  P Kronenberger; R Vrijsen; A Boeyé
Journal:  J Gen Virol       Date:  1992-07       Impact factor: 3.891

2.  Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.

Authors:  J J McSharry; L A Caliguiri; H J Eggers
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

3.  Inhibition of poliovirus uncoating by disoxaril (WIN 51711).

Authors:  H Zeichhardt; M J Otto; M A McKinlay; P Willingmann; K O Habermehl
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

4.  Eclipse products of poliovirus after cold-synchronized infection of HeLa cells.

Authors:  L Everaert; R Vrijsen; A Boeyé
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

Review 5.  Membrane traffic in endocytosis: insights from cell-free assays.

Authors:  J Gruenberg; K E Howell
Journal:  Annu Rev Cell Biol       Date:  1989

6.  Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.

Authors:  M P Fox; M J Otto; M A McKinlay
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

7.  The relationship between penetration and uncoating of poliovirus in HeLa cells.

Authors:  B Mandel
Journal:  Virology       Date:  1967-04       Impact factor: 3.616

8.  Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.

Authors:  J Badger; I Minor; M J Kremer; M A Oliveira; T J Smith; J P Griffith; D M Guerin; S Krishnaswamy; M Luo; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  Effect of arildone on modifications of poliovirus in vitro.

Authors:  L A Caliguiri; J J McSharry; G W Lawrence
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

10.  Entry of poliovirus type 1 and Mouse Elberfeld (ME) virus into HEp-2 cells: receptor-mediated endocytosis and endosomal or lysosomal uncoating.

Authors:  H Zeichhardt; K Wetz; P Willingmann; K O Habermehl
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891
View more
  3 in total

1.  Is the 135S poliovirus particle an intermediate during cell entry?

Authors:  Y Huang; J M Hogle; M Chow
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  The poliovirus 135S particle is infectious.

Authors:  S Curry; M Chow; J M Hogle
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  Imaging poliovirus entry in live cells.

Authors:  Boerries Brandenburg; Lily Y Lee; Melike Lakadamyali; Michael J Rust; Xiaowei Zhuang; James M Hogle
Journal:  PLoS Biol       Date:  2007-07-10       Impact factor: 8.029
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.